Disparities in Breast Cancer Surgery Delay: The Lingering Effect of Race

Annals of Surgical Oncology

Volumn 22, Issue 9, 2015, Pages 2902-2911

  Sheppard, Vanessa B ^a   Oppong, Bridget A ^b   Hampton, Regina ^c   Snead, Felicia ^d   Horton, Sara ^e   Hirpa, Fikru ^f   Brathwaite, Echo J ^f   Makambi, Kepher ^f   Onyewu, S ^e   Boisvert, Marc ^g   Willey, Shawna ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^c Signature Breast Care   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e HOWARD UNIVERSITY HOSPITAL   (United States)

^f GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^g WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLACK PERSON; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CAUCASIAN; CLINICAL STUDY; COMORBIDITY; DISEASE SEVERITY; EMPLOYMENT STATUS; FEMALE; HEALTH CARE DISPARITY; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MARRIAGE; MASTECTOMY; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; PARTIAL MASTECTOMY; RACE; SELF CONCEPT; SOCIAL PSYCHOLOGY; SURGEON; TELEPHONE INTERVIEW; THERAPY DELAY; AFRICAN AMERICAN; ANCESTRY GROUP; BREAST NEOPLASMS; CANCER STAGING; ETHNOLOGY; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; TIME TO TREATMENT; VERY ELDERLY;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HEALTHCARE DISPARITIES; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TIME-TO-TREATMENT;

EID: 84938951379     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4397-3     Document Type: Article

References (50)

1. American Cancer Society. Breast cancer: facts and figures, 2013–2014. http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-042725.pdf. Accessed Jan 2015.
2. Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc. 2002;94:666–8.
3. Komenaka IK, Martinez ME, Pennington RE Jr, et al. Race and ethnicity and breast cancer outcomes in an underinsured population. J Natl Cancer Inst. 2010;102:1178–87.
4. Ferdaus R, Kim MS, Larson JS. Health disparity: time delay in the treatment of breast cancer in Louisiana. J Health Hum Serv Adm. 2011;34:302–24.
5. Dehal A, Abbas A, Johna S. Racial disparities in clinical presentation, surgical treatment and in-hospital outcomes of women with breast cancer: analysis of nationwide inpatient sample database. Breast Cancer Res Treat. 2013;139:561–9.
6. Ryerson AB, Benard VB, Major AC. National breast and cervical cancer early detection program: 1991–2002 national report. http://www.cdc.gov/cancer/nbccedp/pdf/national_report.pdf. Updated 2005. Accessed Oct 14, 2013.
7. Moran MS, Goss D, Haffty BG, Kaufman CS, Winchester DP. Quality measures, standards, and accreditation for breast centers in the United States. Int J Radiat Oncol Biol Phys. 2010;76:1–4.
8. Raval MV, Bilimoria KY, Stewart AK, Bentrem DJ, Ko CY. Using the NCDB for cancer care improvement: an introduction to available quality assessment tools. J Surg Oncol. 2009;99:488–90.
9. Kaufman CS, Shockney L, Rabinowitz B, et al. National quality measures for breast centers (NQMBC): a robust quality tool: breast center quality measures. Ann Surg Oncol. 2010;17:377–85.
10. Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 2013;148:516–23.
11. Shin DW, Cho J, Kim SY, et al. Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer. Ann Surg Oncol. 2013;20:2468–76.
12. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119–26.
13. Eastman A, Tammaro Y, Moldrem A, et al. Outcomes of delays in time to treatment in triple negative breast cancer. Ann Surg Oncol. 2013;20:1880–5.
14. Wagner JL, Warneke CL, Mittendorf EA, et al. Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg. 2011;254:119–24.
15. Bleicher RJ, Ruth K, Sigurdson ER, et al. Preoperative delays in the US Medicare population with breast cancer. J Clin Oncol. 2012;30:4485–92.
16. Pocock B, Nash S, Klein L, El-Tamer M, Schnabel FR, Joseph KA. Disparities in time to definitive surgical treatment between black and white women diagnosed with ductal carcinoma in situ. Am J Surg. 2007;194:521–3.
17. Fedewa SA, Ward EM, Stewart AK, Edge SB. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study, 2004–2006. J Clin Oncol. 2010;28:4135–41.
18. Fedewa SA, Edge SB, Stewart AK, Halpern MT, Marlow NM, Ward EM. Race and ethnicity are associated with delays in breast cancer treatment (2003–2006). J Health Care Poor Underserved. 2011;22:128–41.
19. Desantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer J Clin. 2013;63:151–66.
20. Sturtz LA, Melley J, Mamula K, Shriver CD, Ellsworth RE. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer. BMC Cancer. 2014;14:62.
21. Makoul G, Arntson P, Schofield T. Health promotion in primary care: physician–patient communication and decision making about prescription medications. Soc Sci Med. 1995;41:1241–54.
22. Safran DG, Kosinski M, Tarlov AR, et al. The primary care assessment survey: tests of data quality and measurement performance. Med Care. 1998;36:728–39.
23. Fleming DA, Sheppard VB, Mangan PA, et al. Caregiving at the end-of-life: perceptions of healthcare quality and quality of life among patients and caregivers. J Pain Symptom Manage. 2005;31:407–20.
24. Sheppard VB, Wang J, Yi B, et al. Are health-care relationships important for mammography adherence in Latinas? J Gen Intern Med. 2008;23:2024–30.
25. Bird ST, Bogart LM. Perceived race-based and socioeconomic status (SES)-based discrimination in interactions with health care providers. Ethn Dis. 2001;11:554–63.
26. Thompson HS, Valdimarsdottir HB, Winkel G, Jandorf L, Redd W. The group-based medical mistrust scale: psychometric properties and association with breast cancer screening. Prev Med. 2004;38:209–18.
27. Shelton RC, Clarke Hillyer G, Hershman DL, et al. Interpersonal influences and attitudes about adjuvant therapy treatment decisions among non-metastatic breast cancer patients: an examination of differences by age and race/ethnicity in the BQUAL study. Breast Cancer Res Treat. 2013;137:817–28.
28. Llewellyn-Thomas HA, McGreal MJ, Thiel EC, Fine S, Erlichman C. Patients’ willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med. 1991;32:35–42.
29. Sheppard VB, Wallington SF, Willey SC, et al. A peer-led decision support intervention improves decision outcomes in black women with breast cancer. J Cancer Educ. 2013;28:262–9.
30. Rizzo M, Lund MJ, Mosunjac M, et al. Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer. Cancer. 2009;115:3009–15.
31. Mamounas EP, Tang G, Fisher B, et al. Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor–positive breast cancer: results from NSABP B-14 and NSABP B-20. J Clin Oncol. 2010;28:1677–83.
32. Eknoyan G. Adolphe Quetelet (1796–1874)—the average man and indices of obesity. Nephrol Dial Transplant. 2008;23:47–51.
33. Bustami RT, Shulkin DB, O’Donnell N, Whitman ED. Variations in time to receiving first surgical treatment for breast cancer as a function of racial/ethnic background: a cohort study. JRSM Open. 2014;5:2042533313515863.
34. McGee SA, Durham DD, Tse CK, Millikan RC. Determinants of breast cancer treatment delay differ for African American and white women. Cancer Epidemiol Biomarkers Prev. 2013;22:1227–38.
35. Bilimoria KY, Ko CY, Tomlinson JS, et al. Wait times for cancer surgery in the united states: trends and predictors of delays. Ann Surg. 2011;253:779–85.
36. Simunovic M, Theriault ME, Paszat L, et al. Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993–2000. Can J Surg. 2005;48:137–42.
37. Sheppard VB, Faul LA, Luta G, et al. Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901. J Clin Oncol. 2014;32:2318–27.
38. Fayanju OM, Jeffe DB, Elmore L, Ksiazek DN, Margenthaler JA. Breast cancer patients’ experiences within and outside the safety net. J Surg Res. 2014;190:126–33.
39. Fayanju OM, Jeffe DB, Elmore L, Ksiazek DN, Margenthaler JA. Patient and process factors associated with late-stage breast cancer diagnosis in safety-net patients: a pilot prospective study. Ann Surg Oncol. 2013;20:723–32.
40. Smith SK, Nicolla J, Zafar SY. Bridging the gap between financial distress and available resources for patients with cancer: a qualitative study. J Oncol Pract. 2014;10:e368–72.
41. McMullan M. Patients using the Internet to obtain health information: how this affects the patient–health professional relationship. Patient Educ Couns. 2006;63:24–8.
42. Bender JL, Katz J, Ferris LE, Jadad AR. What is the role of online support from the perspective of facilitators of face-to-face support groups? A multi-method study of the use of breast cancer online communities. Patient Educ Couns. 2013;93:472–9.
43. Bender JL, Jimenez-Marroquin MC, Ferris LE, Katz J, Jadad AR. Online communities for breast cancer survivors: a review and analysis of their characteristics and levels of use. Support Care Cancer. 2013;21:1253–63.
44. Maly RC, Stein JA, Umezawa Y, Leake B, Anglin MD. Racial/ethnic differences in breast cancer outcomes among older patients: effects of physician communication and patient empowerment. Health Psychology. 2008;27:728–36.
45. Bensink ME, Ramsey SD, Battaglia T, et al. Costs and outcomes evaluation of patient navigation after abnormal cancer screening: evidence from the patient navigation research program. Cancer. 2014;120:570–8.
46. Freund KM, Battaglia TA, Calhoun E, et al. Impact of patient navigation on timely cancer care: the Patient Navigation Research Program. J Natl Cancer Inst. 2014;106:dju115.
47. Paskett ED, Katz ML, Post DM, et al. The Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tests? Cancer Epidemiol Biomarkers Prev. 2012;21:1620–8.
48. Madore S, Kilbourn K, Valverde P, Borrayo E, Raich P. Feasibility of a psychosocial and patient navigation intervention to improve access to treatment among underserved breast cancer patients. Support Care Cancer. 2014;22:2085–93.
49. Sheppard VB, Williams KP, Harrison TM, et al. Development of decision-support intervention for black women with breast cancer. Psychooncology. 2010;19:62–70.
50. Davis C, Darby K, Likes W, Bell J. Social workers as patient navigators for breast cancer survivors: what do African-American medically underserved women think of this idea? Soc Work Health Care. 2009;48:561–78.